Levetiracetam versus Carbamazepine in Patients with Late Poststroke Seizures: A Multicenter Prospective Randomized Open-Label Study (EpIC Project) | Zendy

Domenico Consoli | Zendy; Domenico Bosco | Zendy; Paolo Postorino | Zendy; Franco Galati | Zendy; M. Plastino | Zendy; G Perticoni | Zendy; G.A. Ottonello | Zendy; Bruno Passarella | Zendy; Stefano Ricci | Zendy; G. Neri | Zendy; Danilo Toni | Zendy

Open Access

Levetiracetam versus Carbamazepine in Patients with Late Poststroke Seizures: A Multicenter Prospective Randomized Open-Label Study (EpIC Project)

Author(s) -

Domenico Consoli,

Domenico Bosco,

Paolo Postorino,

Franco Galati,

M. Plastino,

G Perticoni,

G.A. Ottonello,

Bruno Passarella,

Stefano Ricci,

G. Neri,

Danilo Toni

Publication year - 2012

Publication title -

cerebrovascular diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.221

H-Index - 104

eISSN - 1421-9786

pISSN - 1015-9770

DOI - 10.1159/000342669

Subject(s) - medicine , levetiracetam , carbamazepine , epilepsy , randomized controlled trial , anesthesia , piracetam , pediatrics , clinical endpoint , psychiatry

Strokes are the leading cause of epileptic seizures in adults and account for 50% of seizures in those over the age of 65 years. The use of antiepileptic drugs to prevent recurrent poststroke seizures is recommended.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research